Akcie v obehu spoločnosti NeuroVive Pharmaceutical AB
Aká je hodnota metriky Akcie v obehu spoločnosti NeuroVive Pharmaceutical AB?
Hodnota metriky Akcie v obehu spoločnosti NeuroVive Pharmaceutical AB je 272.606M 551.18%
Aká je definícia metriky Akcie v obehu?
Akcie v obehu (Shares float) je podiel akcií spoločnosti vlastnených verejnými investormi voči zablokovaným akciám (nie sú voľne v obehu).
Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded
The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.
Akcie v obehu spoločností v sektore Miscellaneous sektor na LSE v porovnaní so spoločnosťou NeuroVive Pharmaceutical AB
Čomu sa venuje spoločnosť NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Firmy s metrikou akcie v obehu podobnou spoločnosti NeuroVive Pharmaceutical AB
- Hodnota metriky Akcie v obehu spoločnosti Cyrela Brazil Realty SA Empreendimentos e Participações je 272.257M 70.81%
- Hodnota metriky Akcie v obehu spoločnosti Ningbo Ronbay New Technology Co je 272.333M 61.44%
- Hodnota metriky Akcie v obehu spoločnosti Fitbit je 272.335M 109.58%
- Hodnota metriky Akcie v obehu spoločnosti Fitbit A Dl ,0001 je 272.335M 111.22%
- Hodnota metriky Akcie v obehu spoločnosti Swiss Re AG je 272.468M 88.78%
- Hodnota metriky Akcie v obehu spoločnosti BeijingWest Industries International je 272.495M 47.45%
- Hodnota metriky Akcie v obehu spoločnosti NeuroVive Pharmaceutical AB je 272.606M 551.18%
- Hodnota metriky Akcie v obehu spoločnosti Foxtons Plc je 272.908M 85.56%
- Hodnota metriky Akcie v obehu spoločnosti NN NV je 272.918M 96.59%
- Hodnota metriky Akcie v obehu spoločnosti Engineers India je 272.932M 48.56%
- Hodnota metriky Akcie v obehu spoločnosti Intuit je 272.978M 106.77%
- Hodnota metriky Akcie v obehu spoločnosti Royal BAM Groep NV je 273.032M 99.90%
- Hodnota metriky Akcie v obehu spoločnosti Forebase International je 273.219M 25.00%